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Abstract
Background: The increasing number of cancer patients has an escalating economic impact to public health
systems (approximately, International dollars- Int$ 60 billion annually in Brazil). Physical activity is widely recognized
as one important modifiable risk factor for cancer. Herein, we estimated the economic costs of colon and post-
menopausal breast cancers in the Brazilian Unified Health System (SUS) attributable to lack of physical activity.
Methods: Population attributable fractions were calculated using prevalence data from 57,962 adults who
answered a physical activity questionnaire in the Brazilian National Health Survey, and relative risks of colon and
breast cancer from a meta-analysis. Annual costs (1 Int$ = 2.1 reais) with hospitalization, chemotherapy and
radiotherapy were obtained from the Hospital and Ambulatory Information Systems of the Brazilian SUS. Two
counterfactual scenarios were considered: theoretical minimum risk exposure level (≥8000 MET-min/week) and
physical activity guidelines (≥600 MET-min/week).
Results: Annually, the Brazilian SUS expended Int$ 4.5 billion in direct costs related to cancer treatment, of which
Int$ 553 million due to colon and breast cancers. Direct costs related to colon and breast cancers attributable to
lack of physical activity were Int$ 23.4 million and Int$ 26.9 million, respectively. Achieving at least the physical
activity guidelines would save Int$ 10.3 mi (colon, Int$ 6.4 mi; breast, Int$ 3.9 mi).
Conclusions: Lack of physical activity accounts for Int$ 50.3 million annually in direct costs related to colon and
post-menopausal breast cancers. Population-wide interventions aiming to promote physical activity are needed to
reduce the economic burden of cancer in Brazil.
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Background
Cancer is the second leading cause of death and
disability-adjusted life years in Brazil [1]. Breast and
colorectal cancer are among the most common cancers,
with an estimated combined number of 137,413 new
cases and 42,924 deaths in 2018 [2]. By 2040, breast and
colorectal cancers are expected to increase over 50% due
to demographic and lifestyle changes [2]. Such an in-
crease in the cancer burden may put further pressure on
an already overwhelmed Brazilian Unified Health System
(Sistema Único de Saúde - SUS), which covers more
than 75% of the population [3, 4].
Physical activity is associated with lower risk of several
types of cancer [5]. In 2018, the World Cancer Research
Fund (WCRF) concluded that strong evidence supports
that physical activity reduces the risk of colon, breast
and endometrial cancers [6]. Nonetheless, dose-response
relationship has been well-characterized for colon and
postmenopausal breast cancers only [7]. Of note, global
estimates suggest that lack of physical activity causes
10% of all breast and colons cancers [8]. To reduce the
risk of these cancers, as well as other non-communicable
diseases, the 2020 World Health Organization (WHO)
guidelines for physical activity and sedentary behaviour
calls for adults to do 150–300min of moderate intensity,
or 75–150min of vigorous-intensity aerobic physical ac-
tivity per week, or any equivalent combination of the iten-
sities [9]. Despite the well-documented health benefits of
reaching physical activity guidelines, global physical activ-
ity levels are not sufficient. In 2016, age-standardized
prevalence of insufficient physical activity was 27.5%, with
a higher prevalence in women (31.7%) than in men
(23.4%) [10]. Latin America and Caribbean countries have
showed the highest prevalence of insufficient physical ac-
tivity (39.1%) worldwide, and Brazil presented the highest
prevalence (47%) within the continent [10].
Insufficient physical activity cost health-care systems
international dollars (Int$) 53.8 billion worldwide in
2013 [11]. Of note, these estimates were calculated con-
sidering direct health-care costs, productivity losses, and
disability-adjusted life-years for coronary heart disease,
stroke, type 2 diabetes, breast cancer, and colon cancer
attributable to insufficient physical activity [11]. In
Brazil, it has been estimated that approximately 10 thou-
sand cancer cases and 3 thousand cancer deaths per year
are attributable to insufficient physical activity [12].
However, to our knowledge, the economic costs of can-
cer in Brazil attributable to lack of physical activity are
unknown, besides its potential to inform the financial
impact of this exposure on the health system [13]. A
cost-of-illness study include direct costs to health
systems, patients and their families, and more broadly,
the indirect costs to society (absenteeism, premature re-
tirement and death). Nonetheless, data on indirect costs
of cancer to society are unavailable in Brazil. On the
other hand, a recent study estimated that approximately
Int$ 7.54 billion were spent with oncological treatment
by the Brazilian federal government from 2001 to 2015,
of which Int$ 3.24 billion with breast cancer patients
and Int$ 1.39 billion with colorrectal cancer patients
[14].
In this study, we estimated the direct health care costs
of colorectal and breast cancers in the Brazilian SUS at-
tributable to lack of physical activity.
Methods
We designed a cost-of-illness study to estimate the
direct costs of colorectal and breast cancers attributable
to lack of physical activity from the perspective of the
Brazilian SUS. This approach uses aggregated disease
costs along with potential impact fraction (PIF) estimates
to calculate the costs attributable to a given risk factor [13].
Direct health care costs of colorectal and breast cancers
Direct health care costs of all cancer (C00-C97), colorec-
tal cancer (C18-C20), colon (C18), breast cancer (C50),
and postmenopausal breast cancer (C50 for women 50
years or older) were obtained from the Brazilian SUS
Ambulatory (Outpatient) Information System (SIA/SUS)
[15] and the Hospital (Inpatient) Information System
(SIH/SUS) [16] in 2017 (herein considered the average
of 2015–2017) based on the International Classification
of Diseases, 10th Revision (ICD-10). SIH/SUS and SIA/
SUS are publicly available and contain deidentified in-
patient and outpatient care data. Direct health care costs
were defined as those of outpatient and inpatient proce-
dures. In our study, we included the following proce-
dures and costs for patients aged 20 years or older:
Outpatient costs: chemotherapy (eg., conventional
chemotherapy, targeted therapy, hormone therapy, im-
munotherapy and supportive therapy) and radiotherapy.
Inpatient costs: surgery and other hospital costs (eg.,
diagnostic and clinical procedures and organ, tissue and
cell transplantation, including chemotherapy during
hospitalization).
We converted the monetary values in Reais (R$) to
Int$, considering the purchasing power parity (PPP) for
2015–2017 (conversion factor 2.10) [17].
Physical activity assessment
Physical activity was obtained from a national represen-
tative health survey conducted in Brazil in 2013, the Na-
tional Health Survey (Pesquisa Nacional de Saúde –
PNS 2013). Details about PNS methods have been re-
ported elsewhere [12]. In this study, we included 57,962
adults aged 20 years or older that responded to a ques-
tionnaire about frequency and duration of recreational, oc-
cupational, commuting to work, commuting to other daily
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activities, and household activities in a typical week. We
assigned metabolic equivalent of tasks (MET) for each ac-
tivity and summed them to obtain total volume of physical
activity (MET-min/week). MET were used to weight differ-
ent types of aforementioned activities according to its in-
tensity (meaning higher intensity having higher weight), as
per the 2011 compendium of physical activities [18]. Details
for these methods has been described elsewhere [12].
All PNS data are available on the Brazilian Institute of
Geography and Statistics (Instituto Brasileiro de Geogra-
fia e Estatística, IBGE) website at: http://www.ibge.gov.
br/home/estatistica/populacao/pns/2013/default_
microdados.shtm. The PNS was approved by Brazil’s
National Research Ethics Committee (Comissão Nacional
de Ética em Pesquisa, CONEP) with the National Health
Council (Conselho Nacional de Saúde) Resolution No.
466/12 (No. 328159, June 26th, 2013), and all participants
signed an informed consent at interview.
Data analysis: cost-of-illness modelling
To estimate the direct health care costs of breast and
colorectal cancers in the Brazilian SUS attributable to
lack of physical activity, we first estimated PIF. Physical
activity has been consistently associated with colon
(C18) and postmenopausal breast cancer (C50 for
women 50 years or older) [7]. Therefore, we first calcu-
lated PIF for colon by sex, and PIF for postmenopausal
breast cancer for women using physical activity data










Pi = proportion of the population at the level i of phys-
ical activity categories;
P’i = proportion of the population at the level i of
physical activity categories in the counterfactual scenario.
In this we considered two counterfactual scenarios: (1)
Theoretical minimum risk exposure level (TMRE): popu-
lation reaching ≥8000 MET-min/week– aka population
attributable fraction (PAF); (2) Physical activity guidelines
(PA guidelines): population reaching at least 600 MET-
min/week.
RRi is the relative risk of postmenopausal breast cancer
and colon cancer at the level i of physical activity cat-
egories. These RR values are currently used in the Glo-
bal Burden of Disease study [7].
Levels i of physical activity were < 600, 600 to 3999,
4000 to 7999, and ≥ 8000 MET-min/week (reference
group), same in the aforementioned dose-response
meta-analysis [7].
PIFs were applied to procedures and costs of hospitali-
zations, chemotherapy and radiotherapy of colon cancer
and postmenopausal breast cancer to calculate the costs
attributable to lack of physical activity. Then, we divided
colon cancer (C18) and postmenopausal breast cancer
(C50 for women 50 years or older) costs attributable to
lack of physical activity by total colorectal (C18-C20)
and breast cancer (C50) costs, respectively. Data analysis
were performed in Stata 15.0 and Microsoft Excel Of-
fice® 2007 spreadsheets.
Results
Table 1 displays the costs of hospitalization, chemother-
apy and radiotherapy by cancer site and sex in Brazil in
2017. Approximately Int$ 4.5 billion was spent on direct
health care related to all cancer types, of which 12.4% or
Int$ 553 million were due to colorectal cancer (Int$ 212
million) and breast cancer (Int$ 341 million). For colo-
rectal cancer, Int$ 121 million were spent on chemo-
therapy, Int$ 82 million on hospitalization, and Int$ 8
million on radiotherapy. Colorectal cancer costs were
similar for men (Int$ 105 million) and women (Int$ 106
million). For breast cancer, Int$ 231 million were spent
on chemotherapy, Int$ 62 million on hospitalization,
and Int$ 48 million on radiotherapy.
Direct costs with colon cancer (Int$ 134 million) rep-
resented 63% of all colorectal cancer costs (Fig. 1 and
Table 2). Considering the TMRE scenario, about Int$ 23
million of colon cancer costs were attributable to lack of
physical activity, which represented 11% of all colorectal
cancer costs. Attributable costs with colon cancer
(Table 2) were slightly higher in women (Int$ 12 mil-
lion) than in men (Int$ 10 million). Most of the attrib-
utable costs were due to chemotherapy (Int$ 15
million), followed by hospitalization (Int$ 8 million)
and radiotherapy (Int$ 48 thousand). In the PA guide-
lines scenario, we estimated that Int$ 6 million could
be potentially saved annually by increasing population-
wide physical activity level to ≥600 MET-min/week, of
which Int$ 4 million on chemotherapy, Int$ 2 million
on hospitalizations and Int$ 13 thousand on
radiotherapy.
Direct costs with postmenopausal breast cancer (Int$
226 million) represented 66% of all breast cancer costs
(Table 3). We estimated that Int$ 26.9 million of post-
menopausal breast cancer costs were attributable to lack
of physical activity, which represents 12% of the post-
menopausal breast cancer costs and 5.6% of all breast
cancer costs. Breast cancer attributable costs were dis-
tributed as follows: Int$ 18.5 million for chemotherapy,
Int$ 4.7 million for hospitalization, and Int$ 3.7 million
for radiotherapy. About Int$ 4 million could be poten-
tially saved annually by reaching PA guidelines, of which
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Int$ 2.6 million on chemotherapy, Int$ 676 thousand on
hospitalizations and Int$ 539 thousand on radiotherapy.
Combined costs of breast and colon cancer attribut-
able to lack of physical activity was Int$ 50.3 million, of
which Int$ 33.9 million were due to chemotherapy, Int$
12.6 million to hospitalizations, and Int$ 3.8 million to
radiotherapy. PA guidelines scenario would result in
Int$ 10.3 million saved annually, of which Int$ 6.9 mil-
lion were due to chemotherapy, Int$ 2.8 million to hos-
pitalizations, and Int$ 552 thousand to radiotherapy.
Discussion
In this study, we estimated the direct costs of colorectal
and breast cancers in the Brazilian SUS attributable to
lack of physical activity. We found that Int$ 26.9 million
of postmenopausal breast cancer and Int$ 23.4 million
of colon cancer costs were attributable to lack of phys-
ical activity in Brazil in 2017. Considering a plausible
counterfactual scenario of reaching at least the physical
activity guidelines would result in Int$ 10.3 million saved
annually.
Cancer has an enormous societal cost. The increasing
number of cancer patients has an escalating economic
impact to public health systems and society. In 2016, it
has been estimated that the cost of cancer to the Brazil-
ian public and private health system was around Int$ 60
billion, which represented around 1.7% of the country’s
Gross Domestic Product per year. Direct costs with in-
patients and outpatients represent around 20% of all
costs [19]. Our study showed that Int$ 553 million (12%)
out of the Int$ 4.5 billion spent with direct health care
related to all cancer in the Brazilian SUS were due to
Fig. 1 Total and attributable direct public health care costs of breast
and colorectal cancers in the Brazilian Health System attributable to
lack of physical activity, 2015-2017*
Table 1 Direct public health care procedures and costs for breast cancer, colorectal cancer, and all cancer in Brazil, 2015–2017a
Procedures,
sex
Breast cancer Colorectal All cancers
Number of
Procedures
Costs (R$) PPP Number of
Procedures




Both 61,990 131,229,010 62,450,354 67,168 173,310,696 82,476,537 1,598,494 3,820,831,624 1,818,289,161
Men NA NA NA 34,128 86,886,272 41,348,162 766,068 1,833,678,694 872,626,282
Women 61,990 131,229,010 62,450,354 33,040 86,424,424 41,128,374 832,426 1,987,152,930 945,662,879
Chemotherapy
Both 1,509,410 485,706,784 231,142,188 154,875 254,701,471 121,209,457 8,917,781 4,321,452,359 2,056,528,724
Men NA NA NA 79,376 125,324,520 59,640,476 3,230,152 1,781,980,080 848,023,515
Women 1,509,410 485,706,784 231,142,188 75,500 129,376,951 61,568,980 5,687,629 2,539,472,279 1,208,505,209
Radiotherapy
Both 66,998 100,279,940 47,722,053 12,414 17,258,377 8,213,060 821,893 1,227,072,660 583,949,552
Men NA NA NA 6746 9,444,164 4,494,367 373,662 565,389,306 269,062,170
Women 66,998 100,279,940 47,722,053 5668 7,814,214 3,718,693 448,231 661,683,353 314,887,383
Total 1,638,398 717,215,734 341,314,594 234,457 445,270,545 211,899,054 11,338,168 9,369,356,643 4,458,767,438
PPP Purchasing power parity in 2015–2017 (conversion factor 2.10). aAverage of costs in 2015–2017
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colorectal cancer (Int$ 212 million) and breast cancer
(Int$ 341 million). Part of these costs could be saved or
reallocated with investments in primary prevention
strategies.
Quantifying the burden of cancer, in terms of cases,
deaths and costs, attributable to modifiable risk factors
can help policymakers to understand the importance of
prioritizing primary prevention strategies. In Brazil, it
has been estimated that about 27% of all cancer cases
and 34% of all cancer deaths could be averted by redu-
cing the prevalence of lifestyle risk factors such as smok-
ing, alcohol consumption, unhealthy diet, overweight
Table 2 Attributable Direct public health care procedures and costs for colon cancer by increasing physical activity in Brazil, 2015–2017a






Costs (R$) PPP Number of
Procedures




Both 43,061 95,493,424 45,444,206 7506 16,648,732 7,922,937 2045 4,522,081 2,152,006
Men 21,320 46,235,648 22,003,005 3549 7,696,932 3,662,880 960 2,080,133 989,911
Women 21,741 49,257,772 23,441,199 3957 8,951,800 4,260,057 1085 2,441,949 1,162,095
Chemotherapy
Both 98,246 185,853,696 88,445,604 17,125 32,397,412 15,417,550 4649 8,794,968 4,185,423
Men 48,101 91,059,408 43,334,109 8015 15,174,362 7,221,302 2170 4,107,295 1,954,614
Women 50,146 94,794,296 45,111,499 9110 17,223,050 8,196,248 2479 4,687,673 2,230,809
Radiotherapy
Both 680 579,535 275,794 119 101,072 48,099 32 27,439 13,058
Men 321 276,443 131,556 54 46,122 21,949 15 12,565 5979
Women 359 303,092 144,238 65 54,951 26,150 18 14,875 7079
Total 141,987 281,926,655 134,165,603 24,750 49,147,216 23,388,586 6726 13,344,488 6,350,486
PPP Purchasing power parity in 2015–2017 (conversion factor 2.10); Colon cancer was defined as ICD C18; TMRE theoretical minimum risk exposure level scenario
(population reaching ≥8000 MET-min/week); PA guidelines: population reaching at least 600 MET-min/week. aAverage of costs in 2015–2017
Table 3 Attributable direct public health care procedures and costs for postmenopausal breast cancer by increasing physical activity
in Brazil, 2015–2017a






Costs (R$) PPP Number of
Procedures




Both 39,684 82,465,568 39,244,401 4717 9,793,987 4,660,844 687 1,420,173 675,844
Men NA NA NA NA NA NA NA NA NA
Women 39,684 82,465,568 39,244,401 4717 9,793,987 4,660,844 687 1,420,173 675,844
Chemotherapy
Both 1,116,395 327,324,128 155,769,731 132,562 38,885,592 18,505,199 19,230 5,647,669 2,687,660
Men NA NA NA NA NA NA NA NA NA
Women 1,116,395 327,324,128 155,769,731 132,562 38,885,592 18,505,199 19,230 5,647,669 2,687,660
Radiotherapy
Both 43,979 65,757,072 31,293,023 5223 7,808,938 3,716,182 758 1,133,530 539,433
Men NA NA NA NA NA NA NA NA NA
Women 43,979 65,757,072 31,293,023 5223 7,808,938 3,716,182 758 1,133,530 539,433
Total 1,200,058 475,546,768 226,307,155 142,501 56,488,517 26,882,225 20,675 8,201,371 3,902,937
PPP Purchasing power parity in 2015–2017 (conversion factor 2.10); Post-menopausal breast cancer was defined as procedures and costs related to ICD C50 in
women aged ≥50 years. TMRE theoretical minimum risk exposure level scenario (population reaching ≥8000 MET-min/week); PA guidelines population reaching at
least 600 MET-min/week. aAverage of costs in 2015–2017
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and obesity and lack of physical activity [20]. Annually,
about 10 thousand cancer cases (3878 colon and 6712
breast) and 3226 cancer deaths (1444 colon and 1782
breast) could be potentially avoided by promoting phys-
ical activity [20]. Our study adds information to these
previous estimates by quantifying the economic burden
of breast and colorectal cancer attributable to lack of
physical activity.
The relationship between physical activity and cancer
have received great attention and sharply increased in the
past few years [5]. Traditionally, physical activity has been
associated with reduced risk of colon and breast cancer in
postmenopausal women, as illustrated in the estimates
from the Global Burden of Disease study [21]. However,
more recently, large pooled data studies including over 1
million participants have suggested that physical activity
may additionally reduce the risk of other types of cancer
such as bladder, breast, endometrial, esophageal, stomach,
glioma, kidney, lung, ovarian, pancreas and prostate [22].
Although the 2018 WCRF report considers convincing/
probable the evidence for inverse association of physical
activity with breast, colon and endometrial only [6], the
American College of Sports Medicine (ACSM) recently
considered strong the evidence for inverse association be-
tween physical activity and seven types of cancer: bladder,
breast, colon, endometrial, esophageal, pancreas and
stomach [23]. Due to these divergences in the literature,
we decided to estimate the cost of breast and colorectal
cancer, which are the most well-established, with available
estimates of dose-response relationship with total physical
activity [7].
To our knowledge, there have a few country-wide
studies on the economic burden of cancer due to lack of
physical activity [11, 24–26]. In the United Kingdom
(UK), insufficient physical activity was responsible for
£1.06 billion to the National Health Service in 2002, with
breast and colon/rectum cancers contributing to £240
and £383 million, respectively [24]. Of note, the UK
study included rectal cancers (C20) in their estimates, al-
though there is limited evidence supporting that physical
activity reduces this type of cancer [6]. A recent study
conducted in the Sweden suggested that insufficient
physical activity was responsible for 0.91% (1.7 billion
Swedish Krona) of total health care costs in 2016, of
which 575 million Swedish Krona were spent with
health care utilization, mortality and early retirement
due to breast and colon cancer [25]. Finally, in the
United States of America, $0.38 billion were spent on
direct costs of breast and $2.0 billion on colon cancers
in 1995 due to lack of physical activity [26]. Although all
studies were conducted in high-income countries,
comparing cancer cost estimates from these studies is
challenging due to its different methods, currencies,
health care systems and year of reference.
The most comprehensive study estimated that insuffi-
cient physical activity cost health care systems Int$ 53.8
billion worldwide in 2013, of which Int$ 2.7 billion were
spent on breast cancer and Int$ 2.5 billion on colon can-
cer [11]. Estimated direct health care costs for breast
and colon cancer varied widely across the globe, from
Int$ 16.7 million in African countries (breast, Int$ 8.8
million; colon, Int$ 7.9 million) to Int$ 5.2 billion
(breast, Int$ 2.7 billion; colon, Int$ 2.5 billion) in the
Western Pacific. In Brazil, direct health care costs for
breast and colon cancer were Int$ 38.3 million and Int$
36.4 million, respectively [11]. Our study provided simi-
lar, but more conservative estimates for the direct
health care costs for breast and colon cancers. These dif-
ferences might due to differences in data sources used to
calculate PIF/PAF estimates, as well as health care costs.
Of note, our study adds information providing direct
costs due to hospitalizations, chemotherapy, and radio-
therapy. In addition, we provided results for two alterna-
tive counterfactual scenarios (TMRE and physical
activity guidelines).
Our study has several limitations. First, we considered
only direct health care costs related to colorectal and
breast cancers, which did not consider indirect costs (eg.
premature mortality, loss of productivity and quality of
life) and out-of-pocket expenditures. Physical activity
may also reduce the risk of other types of cancer not in-
cluded in our analysis [22]. Therefore, our findings
should not be interpreted as the total costs of cancer at-
tributable to lack of physical activity. Second, validated
[27] but self-reported physical activity dates from 2013,
when the most recent national representative health sur-
vey was conducted in Brazil. This may have introduced
misclassification bias due to errors inherent to question-
naires and changes in physical activity over time. Third,
we used RR estimates derived from a dose-response
meta-analysis including studies mainly from US and
Europe [7]. Transportability of RR, and therefore PIF/
PAF estimates, may be biased if the prevalence of poten-
tial effect modifiers in these settings differs from Brazil
[28]. Finally, SUS database gives only information on the
total amount reimbursed by the federal government to
the country’s health services, which did not consider
other modalities of states’ and municipalities’ expendi-
tures. Our cost estimates attributable to lack physical ac-
tivity did not consider other non-communicable diseases
previously linked with physical activity.
Conclusions
Quantifying the economic burden of cancer in the public
health system attributable to modifiable risk factors can
help policymakers to understand and value the import-
ance of primary prevention strategies. Our study pro-
vides evidence on the breast and colorectal cancers
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expenditures attributable to lack of physical activity in
the Brazilian SUS. Annually, around Int$ 50.4 million of
direct colorectal and breast cancers costs are attributable
to lack of physical activity, which represents a substantial
economic burden for the Brazilian health system. Pri-
mary prevention strategies aiming to promote physical
activity, alongside with other health behaviors, are im-
perative to reduce the economic burden of cancer.
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